Beta Bionics, Inc. Common Stock BBNX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.2%+3.2pp | 55.4%+0.3pp | 54.5%+0.5pp | 53.9%— | 53.9%— | |
| Operating margin | -70.1%+7.8pp | -71.5%-2.0pp | -77.4%+8.9pp | -80.1%— | -78%— | |
| Net margin | -60.3%+41.4pp | -73%+11.1pp | -87.9%+12.1pp | -94%— | -101.6%— | |
| Liquidity | ||||||
| Current ratio | 10.7×— | 8.7×— | 10.6×— | —— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $6.10-40.2% | $7.10+118% | $6.76+120% | $6.95— | $10.22— | |
| Valuation | ||||||
| Market capitalization | $708.98M-8.6% | —— | —— | —— | —— | |
| Price / sales | 6.4×— | —— | —— | —— | —— | |
| Price / book | 2.6×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's profit margins?
- Beta Bionics, Inc. Common Stock (BBNX) runs a 57.2% gross margin and a -70.1% operating margin, with a -60.3% net margin.
- Where do Beta Bionics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Beta Bionics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
